Joseph F. Fowler

North American Contact Dermatitis Group Patch Test Results: 2019–2020

Trends in the Prevalence of Methylchloroisothiazolinone/Methylisothiazolinone Contact Allergy in North America and Europe

Oral spleen tyrosine kinase/Janus Kinase inhibitor gusacitinib for the treatment of chronic hand eczema: Results of a randomized phase 2 study

North American Contact Dermatitis Group Patch Test Results: 2017–2018

Prevalence and Trend of Allergen Sensitization in Adults and Children with Atopic Dermatitis Referred for Patch Testing, North American Contact Dermatitis Group Data, 2001-2016

Parabens

Long‐term safety and efficacy of trifarotene 50 μg/g cream, a first‐in‐class <scp>RAR</scp>‐γ selective topical retinoid, in patients with moderate facial and truncal acne

North American Contact Dermatitis Group Patch Test Results: 2015–2016

Epidemiology of nickel sensitivity: Retrospective cross-sectional analysis of North American Contact Dermatitis Group data 1994-2014

Epidemiology of pediatric nickel sensitivity: Retrospective review of North American Contact Dermatitis Group (NACDG) data 1994-2014

Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis

Epidemic of Isothiazolinone Allergy in North America: Prevalence Data From the North American Contact Dermatitis Group, 2013–2014

North American Contact Dermatitis Group Patch Test Results 2013–2014

North American Contact Dermatitis Group Patch Test Results: 2011–2012

Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies.

Patch Testing in Children From 2005 to 2012: Results From the North American Contact Dermatitis Group

Occupational Contact Dermatitis in Hairdressers/Cosmetologists: Retrospective Analysis of North American Contact Dermatitis Group Data, 1994 to 2010